ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

ABBV AbbVie Inc

158,40
-1,21 (-0,76%)
23 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
AbbVie Inc ABBV NYSE Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-1,21 -0,76% 158,40 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
159,46 157,76 160,04 158,26 159,61
mais cotações »

Notícias Recentes

Data Hora Fonte Título
23/05/202417:05PRNUSAbbVie Completes Acquisition of Landos Biopharma
17/05/202408:30PRNUSAbbVie Presents New Data Supporting Leading Gastroenterology..
13/05/202409:39PRNUSAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration..
08/05/202409:00PRNCAQULIPTA™ (atogepant) Now Approved by Health Canada for the..
06/05/202409:00PRNUSAbbVie to Present at the Bank of America Securities..
26/04/202408:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/04/202408:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/04/202409:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/04/202409:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/04/202409:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/04/202408:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/04/202409:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/04/202409:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/04/202409:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
01/04/202408:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
26/03/202408:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
25/03/202412:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25/03/202409:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25/03/202409:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
22/03/202416:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21/03/202409:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
07/03/202410:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
06/03/202410:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
05/03/202414:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
05/03/202410:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
05/03/202409:00PRNCADragonfly has Received Milestone Payment Following Dosing of..
28/02/202402:05PRNUSAbbVie and OSE Immunotherapeutics Announce Partnership to..
27/02/202410:00PRNUSAbbVie to Present at the TD Cowen 44th Annual Health Care..
27/02/202409:45PRNUSU.S. Food and Drug Administration (FDA) Grants Priority..
22/02/202410:05PRNUSAbbVie and Tentarix Announce Collaboration to Develop..
21/02/202410:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024..
20/02/202411:00PRNUSAbbVie Announces Appointment of Robert A. Michael as Chief..
19/02/202410:30PRNUSAbbVie Unveils New Data from Robust Gastroenterology..
15/02/202414:03PRNUSAbbVie Declares Quarterly Dividend
12/02/202409:37PRNUSAbbVie Completes Acquisition of ImmunoGen
08/02/202410:00PRNCAVYALEVMC (solution de foslévodopa/foscarbidopa), médicament..
06/02/202414:00PRNUSCalibr-Skaggs announces expansion of option and license..
02/02/202409:36PRNUSAbbVie Reports Full-Year and Fourth-Quarter 2023 Financial..
31/01/202413:00PRNUSAllergan Aesthetics Releases "Decoding the Future of..
25/01/202405:00PRNUSAllergan Aesthetics Showcases Commitment to Individuality,..
23/01/202410:00PRNUSAllē by Allergan Aesthetics is the Leading Aesthetics..
11/01/202408:18IHMARKETNEWSWall Street Highlights: Mastercard’s Financial Rise,..
09/01/202404:00PRNUSAbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for..
08/01/202411:16DJNAbbVie to Move Lutikizumab Into Phase 3 in Hidradenitis..
08/01/202410:05PRNUSLutikizumab Showed Positive Results in a Phase 2 Trial of..
04/01/202411:29DJNAbbVie, Umoja Biopharma Set CAR-T Cell Therapies..
04/01/202410:45PRNUSAbbVie and Umoja Biopharma Announce Strategic Collaboration..
04/01/202410:00PRNUSAbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings..
03/01/202420:17DJNAbbvie Stock Edges Lower After CVS Says It Will Drop Humira..
03/01/202419:59DJNCVS Health To Cover Humira Biosimilars April 1

Seu Histórico Recente

Delayed Upgrade Clock